Rabbit alpha2-adrenoceptors: both platelets and adipocytes have alpha2A-pharmacology.

Area of Science:

• Pharmacology
• Molecular Biology
• Adrenergic Receptor Research

Background:

• Alpha2-adrenoceptors (alpha2a and alpha2d) share similar sequences but differ in pharmacology.
• Species-specific alpha2-adrenoceptor characteristics have led to suggestions of ortholog relationships.
• Previous studies indicated rabbit adipocytes exhibit alpha2D-adrenoceptor pharmacology, conflicting with functional data.

Purpose of the Study:

• To characterize the alpha2-adrenoceptor in rabbit adipocytes and platelets.
• To compare the pharmacological properties of rabbit alpha2-adrenoceptors with human alpha2a and rat alpha2d subtypes.
• To resolve discrepancies regarding the classification of rabbit alpha2-adrenoceptors.

Main Methods:

• Radioligand binding assays using [3H]RX821002.
• Comparison of drug affinities for rabbit adipocyte/platelet receptors versus human alpha2a and rat alpha2d receptors.
• Utilized norepinephrine and 13 adrenoceptor antagonists.

Main Results:

• Rabbit adipocyte and platelet alpha2-adrenoceptors exhibited highly correlated pharmacological characteristics (r2 = 0.95).
• Drug affinities for these rabbit receptors showed a stronger correlation with human alpha2a-adrenoceptor (r2 = 0.68-0.77) than rat alpha2d-adrenoceptor (r2 = 0.37-0.38).
• Despite low affinity for certain antagonists, rabbit receptors demonstrated alpha2A-adrenoceptor pharmacology.

Conclusions:

• Rabbit adipocyte and platelet alpha2-adrenoceptors possess alpha2A-adrenoceptor pharmacology.
• This classification aligns with functional studies but contrasts with some radioligand binding data.
• Observed differences may stem from sequence variations or environmental factors affecting native vs. recombinant receptors.